Immune response to hepatitis B vaccine in a group of health care workers in Sri Lanka

被引：36

作者：

Chathuranga, L. S. ^{[1
]}

Noordeen, F. ^{[1
]}

Abeykoon, A. M. S. B. ^{[1
]}

机构：

[1] Univ Peradeniya, Fac Med, Dept Microbiol, Peradeniya, Sri Lanka

来源：

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2013年 / 17卷 / 11期

关键词：

Hepatitis B virus; HBsAg vaccine; Health care workers; Anti-HBs; Sri Lanka;

D O I：

10.1016/j.ijid.2013.04.009

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Health care workers (HCWs) are considered at high risk of acquiring the hepatitis B virus (HBV). Seroconversion rates after vaccination against HBV among HCWs have not previously been available in Sri Lanka. In the current study, the response to HBV surface antigen (HBsAg) vaccine was assessed in a selected group of HCWs by testing for antibodies against HBsAg (anti-HBs). This was a retrospective descriptive study to measure the anti-HBs levels, using an ELISA, in an immunized group of HCW referred to Department of Microbiology, Faculty of Medicine, University of Peradeniya, Sri Lanka. Among the 342 participants, 9.9% (n = 34) were non-responders. Female participants had a significantly higher immune response (94.7%) than males (p < 0.05). The results of the study found no significant decline in the immune response with time (p > 0.05). Post HBsAg vaccination immunity in HCW in Sri Lanka is similar to that of global rates with similar gender variation. Anti-HBs levels should be tested in all HCW following HBsAg vaccination so that necessary precautions can be taken. (C) 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

引用

页码：E1078 / E1079

页数：2

共 8 条

[1] Hepatitis B and the Need for a Booster Dose [J].

Leuridan, Elke ;

Van Damme, Pierre .

CLINICAL INFECTIOUS DISEASES, 2011, 53 (01) :68-75

[2]

Lim W. L., 1996, Hong Kong Medical Journal, V2, P138

[3] Antibody levels and protection after hepatitis B vaccination: Results of a 15-year follow-up [J].

McMahon, BJ ;

Bruden, DL ;

Petersen, KM ;

Bulkow, LR ;

Parkinson, AJ ;

Nainan, O ;

Khristova, M ;

Zanis, C ;

Peters, H ;

Margolis, HS .

ANNALS OF INTERNAL MEDICINE, 2005, 142 (05) :333-341

[4] Antibody Levels and Protection after Hepatitis B Vaccine: Results of a 22-Year Follow-Up Study and Response to a Booster Dose [J].

McMahon, Brian J. ;

Dentinger, Catherine M. ;

Bruden, Dana ;

Zanis, Carolyn ;

Peters, Helen ;

Hurlburt, Debbie ;

Bulkow, Lisa ;

Fiore, Anthony E. ;

Bell, Beth P. ;

Hennessy, Thomas W. .

JOURNAL OF INFECTIOUS DISEASES, 2009, 200 (09) :1390-1396

[5] A CONTROLLED CLINICAL-TRIAL OF THE EFFICACY OF THE HEPATITIS-B VACCINE (HEPTAVAX-B) - A FINAL REPORT [J].

SZMUNESS, W ;

STEVENS, CE ;

ZANG, EA ;

HARLEY, EJ ;

KELLNER, A .

HEPATOLOGY, 1981, 1 (05) :377-385

[6] RISK-FACTORS FOR LACK OF DETECTABLE ANTIBODY FOLLOWING HEPATITIS-B VACCINATION OF MINNESOTA HEALTH-CARE WORKERS [J].

WOOD, RC ;

MACDONALD, KL ;

WHITE, KE ;

HEDBERG, CW ;

HANSON, M ;

OSTERHOLM, MT .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (24) :2935-2939

[7] Evaluation of immune response to Hepatitis B vaccine in health care workers at a tertiary care hospital in Pakistan: an observational prospective study [J].

Zeeshan, Mohammad ;

Jabeen, Kauser ;

Ali, Anita Nausheen Akbar ;

Ali, Ailia Wilayat ;

Farooqui, Saadia Z. ;

Mehraj, Vikram ;

Zafar, Afia .

BMC INFECTIOUS DISEASES, 2007, 7 (1)

[8] Immune response to a new hepatitis B vaccine in healthcare workers who had not responded to standard vaccine: Randomised double blind dose-response study [J].

Zuckerman, JN ;

Sabin, C ;

Craig, FM ;

Williams, A ;

Zuckerman, AJ .

BRITISH MEDICAL JOURNAL, 1997, 314 (7077) :329-333

← 1 →